Brief: Acurx Announces Filing Of Provisional Patent Application For Ibezapolstat To Treat Cdi
07/07/2021 14:09
July 7 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX ANNOUNCES FILING OF PROVISIONAL PATENT APPLICATION
FOR
IBEZAPOLSTAT TO TREAT CDI WHILE REDUCING RECURRENCE OF INFECTION
AND IMPROVING THE HEALTH OF THE GUT MICROBIOME
Source text for Eikon: ID:nPn8Zwp0Ka
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln